Cited by 79Liver physiology and pathologyAngiogenesis and VEGF in CancerHepatocellular Carcinoma Treatment and Prognosis

Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist

Martin, T. A., Parr, C., Davies, G., Watkins, G., Lane, J., Matsumoto, K., Nakamura, T., Mansel, R. E. +1 more·2003·Carcinogenesis

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a cytokine primarily produced by stromal fibroblasts and is a known angiogenic and invasion-inducing factor. It is increased in patients with breast cancer. This study examined the effect of NK4, a newly described HGF/SF antagonist, on HGF/SF-promoted growth of a human breast cancer. Both in vitro (invasion and migration assays) and in vivo (murine tumour model) methods were used to ascertain the effect of NK4 on HGF/SF from two sources: human fibroblast-derived HGF/SF and recombinant HGF/SF. In the in vitro invasion assay and migration assay, both HGF/SF and human fibroblasts, which secrete bioactive HGF/SF, increased the invasiveness and migration of the breast cancer cells (MDA MB 231). NK4 significantly reduced this invasiveness and motility. In the animal model, tumour volume and weight was significantly reduced with addition of NK4. It also suppressed HGF/SF-induced growth and markedly retarded tumour growth induced by fibroblasts (MRC5), secreting bioactive HGF/SF. Tumour angiogenesis was assessed by immunohistochemical staining of primary tissue sections using VE-cadherin (an endothelial cell specific cell-cell adhesion molecule). Again, NK4 reduced the effects of both HGF/SF and fibroblasts. We conclude that NK4 has a significant effect on the growth of human breast tumours in nude mice, particularly when stimulated by HGF/SF or fibroblasts. This may occur by decreasing angiogenesis. This gives a clear indication of the therapeutic worth of NK4.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/carcin/bgg072

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bone marrow-derived MSC and adipose-derived stem/stromal cells can secrete a combination of anti-apoptotic and angiogenic factors, including HGF, SDF-1/CXCL12, CD106 and VEGF, which can promote tumor growth, local angiogenesis and metastasis.

    “BM-MSC and ASC can also secrete a combination of anti-apoptotic and angiogenic factors [121], including HGF, SDF-1/CXCL12, CD106 (sVCAM) and VEGF which can promote tumor growth, local angiogenesis and metastasis [42, 84, 122–127].”

    From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [42]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Rosen,E. (1993) Scatter factor induces blood-vessel formation in vivo. Proc. Natl Acad. Sci. USA, 9, 1937±1941.

Cited by

Sorted by citations

Authors
Martin, T. A., Parr, C., Davies, G., Watkins, G., Lane, J., Matsumoto, K., Nakamura, T., Mansel, R. E., & Jiang, W. G.
Affiliations
  • Cardiff University (GB)
  • University of Wales (GB)
  • Osaka University Hospital (JP)
Corresponding author
Martin, T. A.
Venue
Carcinogenesis
Published
2003-05-09
Volume
24
Issue
8
Pages
1317-1323
ISSN
  • 0143-3334 (ISSN-L)
  • 1460-2180
OpenAlex
W2111279109
Cited by
79
References
51
Citations by year
2025: 1 · 2023: 2 · 2022: 2 · 2020: 2 · 2019: 3 · 2017: 3 · 2015: 5 · 2014: 5 · 2013: 5 · 2012: 2
FWCI
4.34
Type
journal article
Language
en
Open access
closed
Locations
  • Carcinogenesis (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancer Research UK
  • Breast Cancer Campaign
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
NK4, hepatocyte growth factor, breast cancer, tumor angiogenesis, tumor growth, tumor invasion, cell migration, MDA-MB-231 cells, MRC-5 fibroblasts, VE-cadherin, angiogenesis inhibitors
MeSH terms
Animals, Breast Neoplasms, Cell Adhesion, Cell Division, Cell Movement, Cytoskeletal Proteins, Disease Models, Animal, Female, Fibroblasts, Humans, Mice, Nude, Mitogens, Neoplasm Invasiveness, Neovascularization, Pathologic, Phosphoproteins, Phosphorylation, Tumor Cells, Cultured, Tyrosine, Blotting, Western, Gene Expression Regulation, Neoplastic, Survival Rate, Hepatocyte Growth Factor, Proto-Oncogene Proteins c-met, Mice, Paxillin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review